The effects of LPM570065, a novel triple reuptake inhibitor, on extracellular serotonin, dopamine and norepinephrine levels in rats.

MLA

Zhang, Renyu, et al. “The Effects of LPM570065, a Novel Triple Reuptake Inhibitor, on Extracellular Serotonin, Dopamine and Norepinephrine Levels in Rats.” PloS One, vol. 9, no. 3, Mar. 2014, p. e91775. EBSCOhost, https://doi.org/10.1371/journal.pone.0091775.

APA

Zhang, R., Li, X., Shi, Y., Shao, Y., Sun, K., Wang, A., Sun, F., Liu, W., Wang, D., Jin, J., & Li, Y. (2014). The effects of LPM570065, a novel triple reuptake inhibitor, on extracellular serotonin, dopamine and norepinephrine levels in rats. PloS One, 9(3), e91775. https://doi.org/10.1371/journal.pone.0091775

Chicago

Zhang, Renyu, Xiang Li, Yanan Shi, Yufeng Shao, Kaoxiang Sun, Aiping Wang, Fengying Sun, et al. 2014. “The Effects of LPM570065, a Novel Triple Reuptake Inhibitor, on Extracellular Serotonin, Dopamine and Norepinephrine Levels in Rats.” PloS One 9 (3): e91775. doi:10.1371/journal.pone.0091775.